ADVERTISEMENT
Search

February 2020

Pharmacy Today logo
Volume 26, Issue 2

Archives   Download TOC  

Current Issue

February 2020 cover

Download  

ADVERTISEMENT
 

Practice & Trends

Community pharmacists can be valuable partners in reducing suicide risk
Practice & Trends

Suicide

Community pharmacists can be valuable partners in reducing suicide risk

Suicide rates in the United States are increasing among males and females, yet community pharmacists who regularly see and provide medications to those suffering with mental health conditions remain an untapped resource for risk reduction efforts, according to a commentary published in the Journal of the American Board of Family Medicine in November 2019.

Charnicia Huggins, PharmD

RSS
Is our profession half full or half empty?

Association Perspective

Is our profession half full or half empty?

I hear a lot of distress among pharmacists across the country, but I also hear pharmacists who are providing new services or growing their involvement into caregiving spaces. Are we about to flourish, or are we a profession in peril?

Thomas E. Menighan, BSPharm, MBA, ScD (Hon), FAPhA, EVP and CEO

RSS

Drugs & Diseases

Cough
Drugs & Diseases

OTCs Today

Cough

Cough—a symptom of diverse infectious and noninfectious disorders that is classified as acute (<3 weeks), subacute (3–8 weeks), or chronic (>8 weeks)—is an important defensive respiratory reflex with potentially significant adverse physical and psychological consequences and economic impact.

Daniel L. Krinsky, RPh, MS

Calcium
Drugs & Diseases

On The Shelf

Calcium

Calcium is the most abundant mineral in the body, with approximately 99% contained in the bones and teeth and the rest in extracellular fluid, intracellular structures, and cell membranes.

Mary Warner

New drug is major breakthrough for many patients with cystic fibrosis
Drugs & Diseases

New Drug

New drug is major breakthrough for many patients with cystic fibrosis

In late October 2019, FDA approved elexacaftor/tezacaftor/ivacaftor and ivacaftor (Trikafta—Vertex Pharmaceuticals), the first triple-combination therapy to treat patients ages 12 years and older with at least one F508del mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene, which is estimated to represent 90% of the cystic fibrosis (CF) population.

Cara Aldridge Young

RSS

Health Systems

Polypharmacy dangerous to patients with heart failure
Health Systems

Heart Failure

Polypharmacy dangerous to patients with heart failure

Heart failure (HF)–exacerbating medications are commonly used in older adults hospitalized for HF and are often continued or even initiated after hospitalization, according to the results of an observational study published on November 8, 2019, in Journal of the American College of Cardiology.

Maria G. Tanzi, PharmDMaria G. Tanzi, PharmDMaria G. Tanzi, PharmDMaria G. Tanzi, PharmD

Reassess safe practices to avoid PCA-by-proxy events
Health Systems

PCA By Proxy

Reassess safe practices to avoid PCA-by-proxy events

A recent event of patient-controlled analgesia (PCA) by proxy—a term used to describe conditions under which someone other than the patient administers one or more doses of an opioid to the patient using the PCA device—has prompted a review of the safeguards needed to prevent these types of events.

Maria Tanzi, PharmD

RSS

CPE

Cultivating resilience in the health professions
CPE

CPE

Cultivating resilience in the health professions

Recently, significant concern has been expressed about the state of the health care workforce. The psychological and emotional well-being of health professionals—including pharmacists—is integral to the success of health care systems. In situations in which health professionals experience feelings of demoralization, hopelessness, or indifference, there are real-world consequences for patient safety, interprofessional collaboration, and delivery of care. 

Zubin Austin, BScPhm, MBA, MISc, PhD, FCAHS

RSS

In this Issue

RSS
ADVERTISEMENT